Xiaoxiao Wang

机构：Nanjing University of Chinese Medicine, Peking University, Peking University People's Hospital, Zhejiang Center for Disease Control and Prevention, China University of Petroleum, East China · ORCID：0000-0003-1654-7302

发表论文 52 篇 · 总被引 295 次 · h-index 9

代表论文

• Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials (2023 · Frontiers in Pharmacology · 被引 28)
• Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α (2024 · Nature Communications · 被引 19)
• Characteristics of the first confirmed case of human infection with mpox virus clade Ib in China (2025 · Nature Communications · 被引 10)
• Tracking the Helicobacter pylori Epidemic in Adults and Children in China (2024 · Helicobacter · 被引 10)
• Exploring the Pathogenesis of Autoimmune Liver Diseases from the Heterogeneity of Target Cells (2024 · Journal of Clinical and Translational Hepatology · 被引 7)
• RETRACTED: Molecular structure of polysaccharide mediated autophagy markers KIF23 and PRC1 proteins and their regulatory role in triple negative cancer through the p53 signaling pathway (2024 · International Journal of Biological Macromolecules · 被引 6)